Stockreport

Iovance Biotherapeutics Inc (IOVA): Jefferies Draws Attention Amtagvi Drug [Yahoo! Finance]

Iovance Biotherapeutics, Inc.  (IOVA) 
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: iovance.com
PDF On April 10, Jefferies reaffirmed a Buy rating and $12 price target on Iovance Biotherapeutics stock, indicating significant upside potential. Iovance Biotherapeutics [Read more]